Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

FDA device deputy: Christy Foreman officially assumes the position of deputy office director for science and regulatory policy in CDRH's Office of Device Evaluation Nov. 7 after serving as acting science deputy since June. Foreman, a longtime FDA staffer who has worked on both the pre-market and post-market sides of CDRH, will oversee ODE's guidance, 513(g) request and de novo review programs, and serve as a liaison to the Office of Science and Engineering Laboratories and the Office of Compliance. ODE's clinical deputy director spot has yet to be permanently filled after Aron Yustein left in March, FDA said. Markham Luke, a Center for Drug Evaluation and Research reviewer and dermatologist, is currently acting in the clinical deputy director role
Advertisement

Related Content

Financings In Brief
Financings In Brief
Advertisement
UsernamePublicRestriction

Register

MT026806

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel